Clinical results of islet transplantation

Pharmacological Research

Volumn 98, Issue , 2015, Pages 86-91

  Maffi, Paola ^a   Secchi, Antonio ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Hypoglycemia unawareness; Insulin independence; Islet

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ARTICLE; DIABETES CONTROL; DISEASE COURSE; DISEASE DURATION; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; RISK BENEFIT ANALYSIS; VASCULAR DISEASE; ANIMAL; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS, TYPE 1; KIDNEY TRANSPLANTATION; METABOLISM; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84930764250     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.04.010     Document Type: Article

References (58)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 353 1993 329 986
2. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, and T.J. Orchard Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N. Engl. J. Med. 353 2005 2643 2653
3. P.E. Cryer Hypoglycemia is the limiting factor in the management of diabetes Diabetes Metab. Res. Rev. 15 1999 42 46
4. E.R. Seaquist, J. Anderson, B. Childs, P. Cryer, S. Dagogo-Jack, and L. Fish Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society Diabetes Care 36 2013 1384 1395
5. A.M. Shapiro, J.R. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, and G.L. Warnock Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N. Engl. J. Med. 343 4 2000 230 238
6. F.B. Barton, M.R. Rickels, R. Alejandro, B.J. Hering, S. Wease, and B. Naziruddin Improvement in outcomes of clinical islet transplantation: 1999-2010 Diabetes Care 35 2012 1436 1445
7. D.M. Thompson, M. Meloche, Z. Ao, B. Paty, P. Keown, and R.J. Shapiro Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy Transplantation 91 3 2011 373 378
8. P. Fiorina, C. Gremizzi, P. Maffi, R. Caldara, D. Tavano, and L. Monti Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients Diabetes Care 28 2005 1358 1365
9. U. Del Carro, P. Fiorina, S. Amadio, L. De Toni Franceschini, A. Petrelli, and S. Menini Evaluation of polineuropathy markers in type 1 diabetic kidney-transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis Diabetes Care 30 12 2007 3063 3069
10. F. D'Addio, P. Maffi, P. Vezzulli, A. Vergani, A. Mello, and R. Bassi Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes Diabetes Care 37 2014 267 276
11. C. Ricordi, P.E. Lacy, E.H. Finke, B.J. Olack, and D.W. Scharp Automated method for isolation of human pancreatic islets Diabetes 37 4 1988 413 420
12. R. Nano, B. Clissi, R. Melzi, G. Calori, P. Maffi, and B. Antonioli Islet isolation for allotransplantation: variables associated with successful islet yield and graft function Diabetologia 48 2005 906 912
13. G.M. Ponte, A. Pileggi, S. Messinger, A. Alejandro, H. Ichii, and D.A. Baidal Toward maximizing the success rates of human islet isolation: Influence of donor and isolation factors Cell Transplant. 16 2007 595 607
14. N. Niclauss, D. Bosco, P. Morel, S. Demuylder-Mischler, C. Brault, and L. Milliat-Guittard Influence of donor age on islet isolation and transplantation outcome Transplantation 91 2011 360 366
15. D.E. Hilling, E. Bouwman, O.T. Terpstra, and P.J. Marang-van de Mheen Effects of donor-, pancreas-, and isolation-related variables on human islet isolation outcome: a systematic review Cell Transplant. 23 2014 921 928
16. A.N. Balamurugan, B. Naziruddin, A. Lockridge, M. Tiwari, G. Loganathan, and M. Takita Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR), 1999-2010 Am. J. Transplant. 14 2014 2595 2606
17. J. Movassat, C. Saulnier, and B. Portha Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats Diabetes 46 1997 1445 1452
18. T. Kitamura, J. Nakae, Y. Kitamura, Y. Kido, W.H. Biggs III, and C.V. Wright The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth J. Clin. Investig. 110 2002 1839 1847
19. F. Bertuzzi, and C. Ricordi Beta-cell replacement in immunosuppressed recipients: old and new clinical indications Acta Diabetol. 44 2007 171 176 10.1007/s00592-007-0020-20-20-20
20. American Diabetes Association Pancreas and islet transplantation in type 1 diabetes Diabetes Care 29 4 2006 935
21. The DCCT Research Group Hypoglycemia in the Diabetes Control and Complications Trial Diabetes 46 1997 271 286
22. R.G. McCoy, H.K. Van Houten, J.Y. Ziegenfuss, N.D. Shah, R.A. Wermers, and S.A. Smith Increased mortality of patients with diabetes reporting severe hypoglycemia Diabetes Care 35 2012 1897 1901
23. M. Venturini, E. Angeli, P. Maffi, P. Fiorina, F. Bertuzzi, and M.V. Salvioni Technique complications and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US Radiology 234 2 2005 617 624
24. P. Maffi, G. Balzano, M. Ponzoni, R. Nano, V. Sordi, R. Melzi, A. Mercalli, M. Scavini, and A. Esposito Autologous pancreatic islet transplantation in human bone marrow Diabetes 62 2013 3523 3531
25. M.R. Rickels, C. Fuller, C. Dalton-Bakes, E. Markmann, M. Palanjian, and K. Cullison Restoration of glucose counterregulation by islet transplantation in long-standing type 1 diabetes Diabetes 2014 141620
26. M. Ang, C. Meyer, M.D. Brendel, R.G. Bretzel, and T. Linn Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes Diabetologia 57 2014 623 632
27. M.D. Bellin, R. Kandaswamy, J. Parkey, H.J. Zhang, B. Liu, and S.H. Ihm Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes Am. J. Transplant. 8 11 2008 2463 2470
28. M.D. Bellin, F.B. Barton, A. Heitman, J.V. Harmon, R. Kandaswamy, and A.N. Balamurugan Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes Am. J. Transplant. 12 6 2012 1576 1583
29. P. Monti, M. Scirpoli, P. Maffi, N. Ghidoli, F. De Taddeo, and F. Bertuzzi Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells J. Clin. Invest. 118 2008 1806 1814
30. B. Keymeulen, E. Vandemeulebroucke, A.G. Ziegler, C. Mathieu, L. Kaufman, and G. Hale Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N. Engl. J. Med. 352 2005 2598 2608
31. K.C. Herold, S. Gitelman, C. Greenbaum, J. Puck, W. Hagopian, and P. Gottlieb Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years Clin. Immunol. 132 2009 166 173
32. A. Rabinovitch, W. Sumoski, R.V. Rajotte, and G.L. Warnock Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture J. Clin. Endocrinol. Metab. 71 1990 152 156
33. X.D. Yang, R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, and R.D. Schreiber Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice: I. The early development of autoimmunity and the diabetogenic process J. Exp. Med. 180 1994 995 1004
34. A. Gangemi, P. Salehi, B. Hatipoglu, J. Martellotto, Barbaro, and J.B. Kuechle Islet transplantation for brittle type 1 diabetes: the UIC protocol Am. J. Transplant. 8 2008 1250 1261
35. M. Qi, K. Kinzer, K.K. Danielson, J. Martellotto, B. Barbaro, and Y. Wang Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience Acta Diabetol. 51 5 2014 833 843
36. T. Froud, R.N. Faradji, A. Pileggi, S. Messinger, D.A. Baidal, and G.M. Ponte The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy and metabolic effects Transplantation 86 1 2008 36 45
37. R.A. DeFronzo, R.E. Ratner, J. Han, D.D. Kim, M.S. Fineman, and A.D. Baron Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes Diabetes Care 28 5 2005 1092 1100
38. Y. Li, T. Hansotia, B. Yusta, F. Ris, P.A. Halban, and D.J. Drucker Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis J. Biol. Chem. 278 1 2003 471 478
39. D.P. Al-Adra, R.S. Gill, S. Imes, D. O'Gorman, T. Kin, and S.J. Axford Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus Transplantation 98 9 2014 1007 1012
40. M.C. Vantyghem, J. Kerr-Conte, L. Arnalsteen, G. Sergent, F. Defrance, and V. Gmyr Primary graft function, metabolic control and graft survival after islet transplantation Diabetes Care 32 2009 1473 1478
41. Y.D. Muller, S. Gupta, P. Morel, S. Borot, F. Bettens, and M.E. Truchetet Transplanted human pancreatic islets after long-term insulin independence Am. J. Transplant. 13 2013 1093 1097
42. H.A. Keenan, J.K. Sun, J. Levine, A. Doria, L.P. Aiello, and G. Eisenbarth Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study Diabetes 59 2010 2846 2853
43. D.M. Radosevich, R. Jevne, M. Bellin, R. Kandaswamy, D.E.R. Sutherland, and B.J. Hering Comprehensive health assessment and five-yr follow-up of allogeneic islet transplant recipients Clin. Transplant. 27 2013 E715 E724
44. P.Y. Benhamou, L. Milliat-Guittard, A. Wojtusciszyn, L. Kessler, C. Toso, and R. Baertschiger on behalf of the GRAGIL group. Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials Diabet. Med. 26 2009 617 621
45. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent mellitus N. Engl. J. Med. 329 1993 977 986
46. P. Fiorina, F. Folli, F. Bertuzzi, P. Maffi, G. Finzi, and M. Venturini Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients Diabetes Care 26 2003 1129 1136
47. M. Venturini, P. Fiorina, P. Maffi, C. Losio, A. Vergani, and A. Secchi Early increase of retinal arterial and venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone Transplantation 81 2006 1274 1277
48. P. Fioretto, M.W. Steffes, D.E. Sutherland, F.C. Goetz, and M. Mauer Reversal of lesions of diabetic nephropathy after pancreas transplantation N. Engl. J. Med. 339 2 1998 69 75
49. P. Fiorina, F. Folli, P. Zerbini, P. Maffi, C. Gremizzi, and V. Di Carlo Islet transplantation is associated with improvement of renal function among uremic patients with type 1 diabetes mellitus and kidney transplants J. Am. Soc. Nephrol. 14 8 2003 2150 2158
50. P. Fiorina, M. Venturini, F. Folli, C. Losio, P. Maffi, and C. Placidi Natural history of kidney graft survival, hypertrophy, and vascular function in end stage renal disease type 1 diabetic kidney transplanted patients: beneficial impact of pancreas and successful islet cotransplantation Diabetes Care 28 6 2005 1303 1310
51. R. Lehmann, J. Graziano, J. Brockmann, T. Pfammatter, P. Kron, and O. de Rougemont Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up Diabetes Care 38 5 2015 752 759
52. T. Kawahara, T. Kin, S. Kashkoush, B. Gala-Lopez, D.L. Bigam, and N.M. Kneteman Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation Am. J. Transplant. 11 2011 2700 2707
53. B.L. Gala-Lopez, P.A. Senior, A. Koh, S.M. Kashkoush, T. Kawahara, T. Kin, A. Humar, and A.M. Shapiro Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation Am. J. Transplant. 11 2011 2708 2714
54. P. Maffi, M. Scavini, C. Socci, L. Piemonti, R. Caldara, and C. Gremizzi Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet Rev. Diabet. Stud. 8 1 2011 44 50
55. P.M. Campbell, A. Salam, E.A. Ryan, P. Senior, B.W. Paty, and D. Bigam Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation Am. J. Transplant. 7 2007 1242 1248
56. E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, and G. Pozza Autoantibody response to islet transplantation in type 1 diabetes Diabetes 50 2001 2464 2471
57. L. Piemonti, M.J. Everly, P. Maffi, M. Scavini, F. Poli, and R. Nano Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes Diabetes 62 5 2013 1656 1664
58. P. Maffi, F. Bertuzzi, F. De Taddeo, P. Magistretti, R. Nano, and P. Fiorina Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy Diabetes Care 30 5 2007 1150 1155